You’re right: there’s a lot of layers and dimensions to the MotrinMoms Twitter storm. I hope it turns out to be a positive lesson for jnj because I think it’s important that the pharmaceutical industry, as any large industry, needs to get social media right.

One thing that I would have added to the discussion is that those of us who are on Twitter tend to be listening within the echo chamber (that is we’re IN Twitter). A lot of companies aren’t – they’re outside the echo chamber.

So they aren’t necessarily coming from our perspective. I’m sure jnj realizes Twitter’s potential, but because they aren’t (I’m supposing here) within the conversation that we’re having, it’s important for us to consider that difference in perspective.

I’m curious to see exactly what jnj learns from this. I’m also curious if they’ll do something as simple as saying to social media evangelists: “Hey, we’re trying to figure this out; we’d really appreciate the help; our industry has unique features that challenge how we get involved. Where should we start.” Whatever they do, I hope the human element shines through.

Inasmuch as some of us are kinda burned out on this matter right now, I hope we do analysis that helps us understand even better how social media impacts all of us.

Again, thanks for the show. I look forward to more!